CA2275971C - Composition for enhancing skin or hair - Google Patents
Composition for enhancing skin or hair Download PDFInfo
- Publication number
- CA2275971C CA2275971C CA002275971A CA2275971A CA2275971C CA 2275971 C CA2275971 C CA 2275971C CA 002275971 A CA002275971 A CA 002275971A CA 2275971 A CA2275971 A CA 2275971A CA 2275971 C CA2275971 C CA 2275971C
- Authority
- CA
- Canada
- Prior art keywords
- skin
- composition
- composition according
- enhancer
- hair
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 91
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 14
- 150000001875 compounds Chemical class 0.000 claims abstract description 42
- 239000003623 enhancer Substances 0.000 claims abstract description 32
- 125000001841 imino group Chemical group [H]N=* 0.000 claims abstract description 12
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims abstract description 9
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 9
- 239000001301 oxygen Substances 0.000 claims abstract description 9
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 9
- 239000011593 sulfur Substances 0.000 claims abstract description 9
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 4
- 239000000490 cosmetic additive Substances 0.000 claims abstract description 4
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 3
- 239000001257 hydrogen Substances 0.000 claims abstract description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 3
- FKUPPRZPSYCDRS-UHFFFAOYSA-N Cyclopentadecanolide Chemical group O=C1CCCCCCCCCCCCCCO1 FKUPPRZPSYCDRS-UHFFFAOYSA-N 0.000 claims description 28
- 239000000463 material Substances 0.000 claims description 17
- 239000000516 sunscreening agent Substances 0.000 claims description 9
- 239000003963 antioxidant agent Substances 0.000 claims description 7
- 235000006708 antioxidants Nutrition 0.000 claims description 7
- 230000003078 antioxidant effect Effects 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 210000003491 skin Anatomy 0.000 description 39
- 230000006872 improvement Effects 0.000 description 11
- YEAYGXLRPMKZBP-KQGICBIGSA-N bis(2-hydroxyethyl)azanium;(e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound OCCNCCO.COC1=CC=C(\C=C\C(O)=O)C=C1 YEAYGXLRPMKZBP-KQGICBIGSA-N 0.000 description 10
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 10
- -1 rejuvinators Substances 0.000 description 9
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 8
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 229960004418 trolamine Drugs 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 7
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 7
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 7
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 7
- 210000004207 dermis Anatomy 0.000 description 7
- 210000002615 epidermis Anatomy 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 6
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 5
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 5
- 229960003415 propylparaben Drugs 0.000 description 5
- 229920002545 silicone oil Polymers 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 4
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 4
- 238000005266 casting Methods 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 229940075507 glyceryl monostearate Drugs 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 229940113174 imidurea Drugs 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 4
- 229960001173 oxybenzone Drugs 0.000 description 4
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- 229920000260 silastic Polymers 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 3
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 3
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 3
- 239000012141 concentrate Substances 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- 229940124274 edetate disodium Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010562 histological examination Methods 0.000 description 3
- 229940078752 magnesium ascorbyl phosphate Drugs 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 3
- 229940101267 panthenol Drugs 0.000 description 3
- 235000020957 pantothenol Nutrition 0.000 description 3
- 239000011619 pantothenol Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 229940108325 retinyl palmitate Drugs 0.000 description 3
- 235000019172 retinyl palmitate Nutrition 0.000 description 3
- 239000011769 retinyl palmitate Substances 0.000 description 3
- 210000004927 skin cell Anatomy 0.000 description 3
- 239000001509 sodium citrate Substances 0.000 description 3
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 230000000475 sunscreen effect Effects 0.000 description 3
- 229940042585 tocopherol acetate Drugs 0.000 description 3
- 238000012876 topography Methods 0.000 description 3
- HTJNEBVCZXHBNJ-XCTPRCOBSA-H trimagnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;diphosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O HTJNEBVCZXHBNJ-XCTPRCOBSA-H 0.000 description 3
- 238000002604 ultrasonography Methods 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 150000003997 cyclic ketones Chemical class 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000002955 immunomodulating agent Substances 0.000 description 2
- 229940121354 immunomodulator Drugs 0.000 description 2
- 229940059904 light mineral oil Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 239000003607 modifier Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 230000037368 penetrate the skin Effects 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- 229940106006 1-eicosene Drugs 0.000 description 1
- FIKTURVKRGQNQD-UHFFFAOYSA-N 1-eicosene Natural products CCCCCCCCCCCCCCCCCC=CC(O)=O FIKTURVKRGQNQD-UHFFFAOYSA-N 0.000 description 1
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 229920002498 Beta-glucan Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Natural products O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 101100257011 Mus musculus Skil gene Proteins 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 210000004082 barrier epithelial cell Anatomy 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229940082484 carbomer-934 Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 231100001030 dermal change Toxicity 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000004890 epithelial barrier function Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000012184 mineral wax Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- NJTGANWAUPEOAX-UHFFFAOYSA-N molport-023-220-454 Chemical compound OCC(O)CO.OCC(O)CO NJTGANWAUPEOAX-UHFFFAOYSA-N 0.000 description 1
- VAMFXQBUQXONLZ-UHFFFAOYSA-N n-alpha-eicosene Natural products CCCCCCCCCCCCCCCCCCC=C VAMFXQBUQXONLZ-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000014366 other mixer Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 150000003146 progesterones Chemical class 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000007388 punch biopsy Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
Abstract
A composition and its use for enhancing the qualities of skin or hair, the composition comprising: (A) a skin-treating compound or a hair-treating compound; (B) an enhancer having structure (I) wherein: X an d Y are oxygen, sulfur, or an imino group of the structure =N-R, with the proviso that when Y is the imino group, X is an imino group a nd when Y is sulfur, X is sulfur or an imino group; A is a group having the structure (a) wherein X and Y are defined; m and n are integers having a value of from 1 to 20 and the sum of m + n is not greater than 25; p is an integer having a value of 0 or 1; q is an integ er having a value of 0 or 1; r is an integer having a value of 0 or 1; and R is hydrogen or an alkyl group having from 1 to 6 carbon atoms and m ay be straight chained or branched; with the proviso that when p, q and r have a value of 0 and Y is oxygen, m + n is at least 11; (C) a carrier; and optionally (D) a cosmetic additive.
Description
COMPOSITION FOR ENHANCING SKIN OR HAIR
Field of the Invention This invention relates to means for improving a physiologic condition of the body. More particularly, this invention relates to a composition which is effective in enhancing the qualities of skir.t or hair.
It is known that there are various types of materials which are effective in enhancing various properties of the skin, for example, properties such as smoothness of the skin and texture of the skin. Examples of such materials are vitamins, anti-oxidants growth factors and steroids.
Similarly, it is known that there are various types of materials which are effective in enhancing various properties of hair, including, for example, materials which function as hair conditioners and materials which function to improve the manageability of hair.
The present invention relates to the provision of an improved composition for enhancing the qualities of skin or hair.
Summary of the Invention In accordance with the present invention, there is provided a composition which is effective in enhancing the qualities of skin or hair and which comprises: (A) a skin-treating or hair-treating compound; (B) an enhancer, as described below; (C) a carrier; and optionally (D) a cosmetic additive.
Another aspect of the present invention is the provision of a method for enhancing one or more properties of the skin or hair comprising applying to the skin or hair a composition of the present invention. In preferred form, the composition is applied to the bodily part in the form of a cream or lotion.
Numerous benefits which are provided by the present invention will be evident from examples set forth below.
Detailed Description of the Invention As set forth above, the composition of the present invention comprises a skin- or hair-treating compound, an enhancer, a carrier, and optionally a cosmetic additive.
The term "skin-treating compound" means a material which is effective in enhancing one or more properties of skin as evidenced by statistically significant differences between the quality of untreated skin and skin treated with said material, at the 95% level. of confidence, using standard methods of evaluation which are known to persons skilled in the art. Examples of skin char=acteristics or properties that are capable of being improved by a skin-treating compound include: (A) smoothness of the skin; (B) thickness of the epidermal layer of the skin; (C) increase in the cellular density of the skin; (D) reduction in the depth of interossei; (E) elasticity of the skin; and (F) texture of the skin. Methods for evaluating in an objective way skin properties of the aforementioned type are well known to persons skilled in the art. They include, for example, the use of clinical assessments, photographic assessments, silastic castings, ultra-sound evaluation, histological examination, punch biopsies, and tape stripping.
Examples of classes of materials for use as skin-treating compounds in the practice of the present invention include nutrients, modifiers, rejuvinators, hormones, regulators, immunomodulators, moisturizers, and stimulators.
Examples of skin-treating materials for use in the practice of the present invention include: nutrients - vitamins, amino acids, and carbohydrates; modifiers - melanin and antioxidants; rejuvinators - growth factors and human growth hormones; hormones - estrogens, progesterones and other steroids, and growth hormones; regulators - peptides, proteins, and anti-sense variations; immunomodulators - beta 1, 3-glucan and farnesol; moisturizers - vegetable oils, beeswax, and other waxes, lanolins, fatty acid esters, mineral oils, and other hydrophobic materials; and stimulators - tocopheryl nicotiinate, retinoids, and alpha-hydroxy acids. A plurality of :skin-treating compounds can be used in the composition.
The minimum percent improviament which is imparted by the skin-treating compound(s) to the skin and which constitutes a statistically significant difference, as referred to hereinabove, will vary depending on the skin property being evaluated, as well as on sample size and distribution. For example, in evaluating epidermal thickness, an improvement of 10 % or greater is considered by persons skilled in the art as a statistically significant difference. On the other hand, in evaluating elasticity of skin, an improvement of at least about 30 % would be considered by persons skilled in the art as constituting a statistically significant difference.
The skin-treating compound(s) is used in conjunction with an enhancer which is a compound within the scope of Formula I below.
y (X)q C--2 5 _q--_ R FORMULA I
(C12)n ( CH2 ) m I
I
(A)r ~
(CH =CH)p wherein: X and Y are oxygen, sulfur, or an imino group of the structure =N-R, with the proviso that when Y is the imino group, X is an imino group and when Y is sulfur, X is sulfur Y
or an imino group; A is a group having the structure 11 -C - x wherein X and Y are defined; m and n are integers having a value of from 1 to 20 and the sum of m+ n is not greater than 25; p is an integer having a value of 0 or 1; q is an integer having a value of 0 or 1; r is an integer having a value of 0 or 1; and R is hydrogen or an alkyl group having 4, PCT/1JS97/00154 from 1 to 6 carbon atoms and may be straight chained or branched; with the proviso that: when p, q and r have a value of 0 and Y is oxygen, m + n is at least 11. When R is alkyl, it can be, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec - butyl, amyl, hexyl, and the like. A
plurality of enhancers can be used. The enchancers for use in the practice of this invention are non-toxic and are compatible with skin/hair treating compounds which comprise the composition of this invention. Additional improvements in the qualities of the skin are achieved by the use of the enhancer(s) in combination with the skin-treating compound.
Such improvements are identified and evaluated by use of the same type of methodologies referred to hereinabove in connection with the skin-treating compound(s).
Preferably, the enhancer is a cyclic lactone compound wherein both X and Y are oxygen, q is 1 and r is 0, a cyclic diester (compounds wherein both X and Y are oxygen and both q and r are 1), and a cyclic ketone (compounds wherein both q and r are 0 and Y is oxygen). When the enhancer is a cyclic diester, m+n is preferably at least 3. When the enhancer is a cyclic ketone, m+n is preferably from 11 to 15 and p is preferably 0. Particularly preferred enhancers for use of the practice of the present invention include macrocylcic ketones and lactones of Formula I above. A highly preferred enhancer is cyclopentadecanolide.
The skin-treating compound or a mixture of skin-treating compounds should be used in an amount which is effective in improving the quality of the skin. The minimum amount(s) needed to achieve the improvemeint will vary depending on the particular skin-treating compound or mixture of skin-treating compounds that are used. Generally speaking, it is believed that the skin-treating compound(s) will comprise at least about 0.01 wt.% of the composition. Typically, the skin-treating compound(s) will comprise about 0.1 to about 10 wt.%
of the composition. Preferably,, the skin-treating compound(s) will comprise about 0.5 to about 3 wt.% of the composition.
The enhancer or a mixture of enhancers can be used in an amount at least effective to impart additional improvements to the skin, that is, improvements beyond those provided by the skin-treating compound. It is believed that, for most applications, the enhancer will comprise about 0.1 to about 30 wt.% of the composition, with a preferred range of enhancer being about 0.5 to about 10 wt.%, and a particularly preferred range comprising about 2 to about 5 wt.% of the composition.
The skin-improving composition of the present invention will generally include also a carrier in which the other ingredients comprising the composition are either dissolved or dispersed in the form of solid particles or liquid droplets. Any suitable material can be used as the carrier, for example, materials which are suitable for use in pharmaceutical and cosmetic compositions. Examples of carriers include water, alcohol, glycerine, sorbitol, propylene glycol, vegetable- and animal-derived oils, waxes, acids, alcohols, esters, ethers, amides, ethoxylates and propoxylates, ethylene and propylene glycol ethers, mineral oils and waxes, silicone oils and waxes, and surfactants.
The carrier can comprise one or more compounds. Speaking generally, the carrier will comprise about 10 to about 95 wt.% of the composition.
Optionally, but typically, the composition will include also one or more compounds which impart other desired properties to the composition. Such compounds will typically comprise materials of the type that are used as additives in cosmetic compositions. Examples of such materials are fragrances, colorants, includinq pigments or dyes, preservatives, thickening agents, pH controlling agents, stabilizers, surfactants, and emulsifiers.
The form of the composition can be liquid, semi-solid, or solid. The composition can be formulated so that it can be dispersed from an aerosol coritainer. For convenience and ease of application, the use of the composition in a cream or lotion form is recommended.
The skin-improving composition can be applied to the skin as often as needed to achieve the desired improvements.
The frequency of application will vary depending on the nature of the composition and tY:ie involved skin condition.
Field of the Invention This invention relates to means for improving a physiologic condition of the body. More particularly, this invention relates to a composition which is effective in enhancing the qualities of skir.t or hair.
It is known that there are various types of materials which are effective in enhancing various properties of the skin, for example, properties such as smoothness of the skin and texture of the skin. Examples of such materials are vitamins, anti-oxidants growth factors and steroids.
Similarly, it is known that there are various types of materials which are effective in enhancing various properties of hair, including, for example, materials which function as hair conditioners and materials which function to improve the manageability of hair.
The present invention relates to the provision of an improved composition for enhancing the qualities of skin or hair.
Summary of the Invention In accordance with the present invention, there is provided a composition which is effective in enhancing the qualities of skin or hair and which comprises: (A) a skin-treating or hair-treating compound; (B) an enhancer, as described below; (C) a carrier; and optionally (D) a cosmetic additive.
Another aspect of the present invention is the provision of a method for enhancing one or more properties of the skin or hair comprising applying to the skin or hair a composition of the present invention. In preferred form, the composition is applied to the bodily part in the form of a cream or lotion.
Numerous benefits which are provided by the present invention will be evident from examples set forth below.
Detailed Description of the Invention As set forth above, the composition of the present invention comprises a skin- or hair-treating compound, an enhancer, a carrier, and optionally a cosmetic additive.
The term "skin-treating compound" means a material which is effective in enhancing one or more properties of skin as evidenced by statistically significant differences between the quality of untreated skin and skin treated with said material, at the 95% level. of confidence, using standard methods of evaluation which are known to persons skilled in the art. Examples of skin char=acteristics or properties that are capable of being improved by a skin-treating compound include: (A) smoothness of the skin; (B) thickness of the epidermal layer of the skin; (C) increase in the cellular density of the skin; (D) reduction in the depth of interossei; (E) elasticity of the skin; and (F) texture of the skin. Methods for evaluating in an objective way skin properties of the aforementioned type are well known to persons skilled in the art. They include, for example, the use of clinical assessments, photographic assessments, silastic castings, ultra-sound evaluation, histological examination, punch biopsies, and tape stripping.
Examples of classes of materials for use as skin-treating compounds in the practice of the present invention include nutrients, modifiers, rejuvinators, hormones, regulators, immunomodulators, moisturizers, and stimulators.
Examples of skin-treating materials for use in the practice of the present invention include: nutrients - vitamins, amino acids, and carbohydrates; modifiers - melanin and antioxidants; rejuvinators - growth factors and human growth hormones; hormones - estrogens, progesterones and other steroids, and growth hormones; regulators - peptides, proteins, and anti-sense variations; immunomodulators - beta 1, 3-glucan and farnesol; moisturizers - vegetable oils, beeswax, and other waxes, lanolins, fatty acid esters, mineral oils, and other hydrophobic materials; and stimulators - tocopheryl nicotiinate, retinoids, and alpha-hydroxy acids. A plurality of :skin-treating compounds can be used in the composition.
The minimum percent improviament which is imparted by the skin-treating compound(s) to the skin and which constitutes a statistically significant difference, as referred to hereinabove, will vary depending on the skin property being evaluated, as well as on sample size and distribution. For example, in evaluating epidermal thickness, an improvement of 10 % or greater is considered by persons skilled in the art as a statistically significant difference. On the other hand, in evaluating elasticity of skin, an improvement of at least about 30 % would be considered by persons skilled in the art as constituting a statistically significant difference.
The skin-treating compound(s) is used in conjunction with an enhancer which is a compound within the scope of Formula I below.
y (X)q C--2 5 _q--_ R FORMULA I
(C12)n ( CH2 ) m I
I
(A)r ~
(CH =CH)p wherein: X and Y are oxygen, sulfur, or an imino group of the structure =N-R, with the proviso that when Y is the imino group, X is an imino group and when Y is sulfur, X is sulfur Y
or an imino group; A is a group having the structure 11 -C - x wherein X and Y are defined; m and n are integers having a value of from 1 to 20 and the sum of m+ n is not greater than 25; p is an integer having a value of 0 or 1; q is an integer having a value of 0 or 1; r is an integer having a value of 0 or 1; and R is hydrogen or an alkyl group having 4, PCT/1JS97/00154 from 1 to 6 carbon atoms and may be straight chained or branched; with the proviso that: when p, q and r have a value of 0 and Y is oxygen, m + n is at least 11. When R is alkyl, it can be, for example, methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec - butyl, amyl, hexyl, and the like. A
plurality of enhancers can be used. The enchancers for use in the practice of this invention are non-toxic and are compatible with skin/hair treating compounds which comprise the composition of this invention. Additional improvements in the qualities of the skin are achieved by the use of the enhancer(s) in combination with the skin-treating compound.
Such improvements are identified and evaluated by use of the same type of methodologies referred to hereinabove in connection with the skin-treating compound(s).
Preferably, the enhancer is a cyclic lactone compound wherein both X and Y are oxygen, q is 1 and r is 0, a cyclic diester (compounds wherein both X and Y are oxygen and both q and r are 1), and a cyclic ketone (compounds wherein both q and r are 0 and Y is oxygen). When the enhancer is a cyclic diester, m+n is preferably at least 3. When the enhancer is a cyclic ketone, m+n is preferably from 11 to 15 and p is preferably 0. Particularly preferred enhancers for use of the practice of the present invention include macrocylcic ketones and lactones of Formula I above. A highly preferred enhancer is cyclopentadecanolide.
The skin-treating compound or a mixture of skin-treating compounds should be used in an amount which is effective in improving the quality of the skin. The minimum amount(s) needed to achieve the improvemeint will vary depending on the particular skin-treating compound or mixture of skin-treating compounds that are used. Generally speaking, it is believed that the skin-treating compound(s) will comprise at least about 0.01 wt.% of the composition. Typically, the skin-treating compound(s) will comprise about 0.1 to about 10 wt.%
of the composition. Preferably,, the skin-treating compound(s) will comprise about 0.5 to about 3 wt.% of the composition.
The enhancer or a mixture of enhancers can be used in an amount at least effective to impart additional improvements to the skin, that is, improvements beyond those provided by the skin-treating compound. It is believed that, for most applications, the enhancer will comprise about 0.1 to about 30 wt.% of the composition, with a preferred range of enhancer being about 0.5 to about 10 wt.%, and a particularly preferred range comprising about 2 to about 5 wt.% of the composition.
The skin-improving composition of the present invention will generally include also a carrier in which the other ingredients comprising the composition are either dissolved or dispersed in the form of solid particles or liquid droplets. Any suitable material can be used as the carrier, for example, materials which are suitable for use in pharmaceutical and cosmetic compositions. Examples of carriers include water, alcohol, glycerine, sorbitol, propylene glycol, vegetable- and animal-derived oils, waxes, acids, alcohols, esters, ethers, amides, ethoxylates and propoxylates, ethylene and propylene glycol ethers, mineral oils and waxes, silicone oils and waxes, and surfactants.
The carrier can comprise one or more compounds. Speaking generally, the carrier will comprise about 10 to about 95 wt.% of the composition.
Optionally, but typically, the composition will include also one or more compounds which impart other desired properties to the composition. Such compounds will typically comprise materials of the type that are used as additives in cosmetic compositions. Examples of such materials are fragrances, colorants, includinq pigments or dyes, preservatives, thickening agents, pH controlling agents, stabilizers, surfactants, and emulsifiers.
The form of the composition can be liquid, semi-solid, or solid. The composition can be formulated so that it can be dispersed from an aerosol coritainer. For convenience and ease of application, the use of the composition in a cream or lotion form is recommended.
The skin-improving composition can be applied to the skin as often as needed to achieve the desired improvements.
The frequency of application will vary depending on the nature of the composition and tY:ie involved skin condition.
In general, the application of the composition twice a day (for example, in the morning and the evening) will be suitable for treating many conditions and can be continued for as long as is required to obtain the desired results, for example, weeks or months or indefinitely. For some conditions, the composition can be applied every two or three days. In treating the skin of the hands, consideration should be given to applying the composition after every washing.
Compositions for treating hair are also within the scope of the present invention. Such compositions can comprise hair-treating compounds, for example, materials which function as hair conditioners and compounds which improve the manageability of hair. Such coinpositions can comprise a hair-treating compound and the enhancer of Formula I above, as well as other ingredients, and in amounts as described above in connection with the skin-improving composition.
It should be appreciated also that the enhancer of the present invention can be used to advantage in any type of skin-enhancing composition which includes one or more skin-treating compounds that do not readily or easily penetrate the skin epithelial barrier. Such compositions are well known to those skilled in the art. An exemplary class of such compositions is an anti-oxidant composition. Such compositions typically comprise a variety of natural nutrients, including, for example, vitamins, which function to rejuvenate the skin, retard the signs of aging of the skin and maintain the vitality of skin cells. In an in vivo comparative study involving the use of an anti-oxidant composition within the scope of the present invention and Retin A, a material whose anti-wrinkle property has been well documented, it was determined that the performance of the composition of the present invention was equal to that of Retin A in terms of effecting an increase in epithelial thickness, but without the side effects experienced with Retin A.
Examples 1 to 3 below are illustrative of anti-oxidant compositions which promote the natural repair process and retard aging of the skin by providing skin cells with beneficial natural nutrients. The enhancer used in the compositions is cyclopentadecanolide. It is believed that the enhancer functions to aid in the delivery of the nutrients effectively to the skin cells for their nourishment. This results in rejuvenation of the skin, imparting to the skin a radiant and youthful appearance. The principal variations among the compositions are related to differences in viscosity and concentrations of ingredients.
Such differences illustrate that the compositions can be tailor-made for ease and effectiveness of application - for example, for repetitive use during the day, especially after each time the body or parts of the body, such as the hands, are washed or otherwise cleaned, or for application at night prior to sleep.
Example 1- Hand and Body Lotion Vitamin A Palmitate 0.38% w/w Magnesium Ascorbyl Phosphate 0.75 Vitamin E Acetate 0.38 Alpha-Bisabolol 0.38 Panthenol (Pantothenyl Alcohol) 0.25 Edetate Disodium 0.10 Sodium Citrate 0.60 Trolamine (Triethanolamine) 1.70 Diethanolamine Methoxycinnamate (DEA Methoxycinnamate) 2.00 Aloe Vera Gel Concentrate 1.00 Beeswax, White 0.50 Mineral Oil, Light 4.00 Cetyl Palmitate 1.00 Soya Sterol 1.00 _ Cetyl Alcohol 2.00 Stearic Acid 3.00 Carbomer 934 0.10 Poly(Vinylpyrrolidone)/1-Eicosene Copolymer 1.00 Methylparaben'm 0.20 Propylparaben 7" 0.10 Imidazolidinyl Urea (Imidurea) 0.30 Bu.tylated Hydroxytoluene (BHT) 0.20 Cyclopentadecanolide 4.00 Fragrance QS
Water oS
Total 100.00% w/w Example 2 - Hand and Body Cream Vitamin A Palmitate 0.50 w/w Magnesium Ascorbyl Phosphate 0.75%
Vitamin E Acetate 1.50 Alpha-Bisabolol 1.00 Panthenol (Pantothenyl Alcohol) 1.00 Edetate Disodium 0.10 Sodium Citrate 0.60 Trolamine (Triethanolamine) 0.50 Diethanolamine Methoxycinnamate (DEA Methoxycinnamate) 2.00 Aloe Vera Gel Concentrate 1.00 Squalane 3.00 Cetyl Esters 2.00 Stearyl Alcohol 4.00 PEG-40 Stearate 4.00 Glyceryl Monostearate 3.00 Methylparaben 0.20 Propylparaben 0.10 Imidazolidinyl Urea (Imidurea) 0.30 Butylated Hydroxytoluene (BHT) 0.20 Silicone Oils 5.50 Cyclopentadecanolide 4.00 Fragrance QS
Water os Total 100.00% w/w Example 3 - Niqht Cream Vitamin A Palmitate 0.375% w/w Magnesium Ascorbyl Phosphate 3.000 Vitamin E Acetate 1.500 Alpha-Bisabolol 1.000 Panthenol (Pantothenyl Alcohol) 1.000 Edetate Disodium 0.100 Sodium Citrate 0.600 Trolamine (Triethanolamine) 0.500 Diethanolamine Methoxycinnamate (DEA Methoxycinnamate) 2.000 Aloe Vera Gel Concentrate 1.000 Squalane 3.000 Cetyl Esters 2.000 Mineral Oil, Light 4.000 Stearyl Alcohol 4.000 PEG-40 Stearate 2.500 Glyceryl Monostearate 4.500 Methylparaben 0.200 Propylparaben 0.100 Imidazolidinyl Urea (Imidurea) 0.300 Butylated Hydroxytoluene (BHT) 0.200 Silicone Oils 5.000 Cyclopentadecanolide 4.000 Fragrance QS
Water os Total 100.00% w/w The ingredients of the compositions of Examples 1 to 3 are formulated into a substantially homogeneous composition with standard mixing, stirring, or shearing equipment, including high shear, as well as motionless or other mixers, for example, at room temperature - 90 C, to form a creamy emulsion or lotion with a smooth feeling. The resultant compositions can be packaged, as appropriate, in plastic or aluminum tubes, glass or plastic: jars, or glass or plastic bottles. The compositions evidence gross physical stability even under drastic conditions, for example, at 60 C for 3 months.
The hand and body cream of Example 2 is evaluated for effectiveness in tests involvincf humans (15 caucasians, aged 50 years and older). The test subjects use the composition of Example 2 or a placebo cream, according to the blind code, for the first 2 months and then all subjects use the composition of Example 2. The test compositions are rubbed into the hands daily at night before the test subjects retire. The following techniques are used to evaluate the performance of the composition on the back of the hand: (A) photographs; (B) silastic castings; (C) ultrasound B-mode scans; (D) biopsies for histological examination; and (E) ballistometry. The overall effects observed as a result of the use in the evaluations of the composition of Example 2 are summarized hereafter.
On the basis of photographic assessments (A) above, a comparison of the subjects shows a gradual improvement in the appearance of the dorsal surface of the hands as a result of the use of the composition of Example 2. Study of the photographs reveal that there is a decrease in the number of lines, a decrease in the depth of the interossei, and a general improvement in the smoothness of the skin. Use of composition of Example 2 appears to improve both the quality of the stratum corneum and the hydration of the epidermis and dermis. Improvement in the interossei depth, as manifested by a decrease in the depth, would indicate a dermal improvement.
Silastic castings of (B) above are evaluated and compared by two independent scorers. Changes in the skin's topography are rated according -to the following scale:
positive response; no response or no change; and negative response or worsening. These results are then averaged. At 30 days, there is no significanit difference in the skin's topography. At 90 days, the silastic castings show that 60%
of the subjects exhibited a positive response in the skin's topography, and at 180 days, 731s of the subjects have a positive response.
On the basis of ultrasound evaluation of (C) above, the overall effects which are produced by use of the composition of Example 2 can be summarized by three observations: (1) the epidermis in most of the subjects becomes thicker and better hydrated; (2) the papillary derrnis increases in density; and (3) the reticular dermis increases in density. The time course of events shows a gradua7L increase in thickness and density to up to three or four months. After this period, the increase reaches a steady state or declines slightly.
These findings suggest an initial proliferative effect of the product on the epidermis followe:d by dermal restructuring.
From histological examination of (D) above, the stained sections are examined and evaluated for the following parameters: (1) epidermal thickriess; (2) size of the granular layer; (3) appearance of the stratum corneum; and (4) appearance of the dermis. Epidermal thickness increases by 19% over the course of the study, with a 50% increase being found in epidermal thickness in some subjects. Granular layer increases in all subjects to at least double in thickness. This increase is estimated by the number of granular cells. Stratum corneuni appearance is markedly different in most subjects. From a compacted initial appearance, the stratum corneum assumes a basket weave pattern that is associated with a younger epidermis. Dermal evaluation is difficult to assess in that no special stains are used. Overall most subjects will show an increase in cellularity of the dermis. This finding would be consistent with a restructuring process of the dermis.
On the basis of ballistometer evaluation of (E) above, 10 subjects have a positive response and 4 subjects have no significant change. One subject has a negative response.
Compositions for treating hair are also within the scope of the present invention. Such compositions can comprise hair-treating compounds, for example, materials which function as hair conditioners and compounds which improve the manageability of hair. Such coinpositions can comprise a hair-treating compound and the enhancer of Formula I above, as well as other ingredients, and in amounts as described above in connection with the skin-improving composition.
It should be appreciated also that the enhancer of the present invention can be used to advantage in any type of skin-enhancing composition which includes one or more skin-treating compounds that do not readily or easily penetrate the skin epithelial barrier. Such compositions are well known to those skilled in the art. An exemplary class of such compositions is an anti-oxidant composition. Such compositions typically comprise a variety of natural nutrients, including, for example, vitamins, which function to rejuvenate the skin, retard the signs of aging of the skin and maintain the vitality of skin cells. In an in vivo comparative study involving the use of an anti-oxidant composition within the scope of the present invention and Retin A, a material whose anti-wrinkle property has been well documented, it was determined that the performance of the composition of the present invention was equal to that of Retin A in terms of effecting an increase in epithelial thickness, but without the side effects experienced with Retin A.
Examples 1 to 3 below are illustrative of anti-oxidant compositions which promote the natural repair process and retard aging of the skin by providing skin cells with beneficial natural nutrients. The enhancer used in the compositions is cyclopentadecanolide. It is believed that the enhancer functions to aid in the delivery of the nutrients effectively to the skin cells for their nourishment. This results in rejuvenation of the skin, imparting to the skin a radiant and youthful appearance. The principal variations among the compositions are related to differences in viscosity and concentrations of ingredients.
Such differences illustrate that the compositions can be tailor-made for ease and effectiveness of application - for example, for repetitive use during the day, especially after each time the body or parts of the body, such as the hands, are washed or otherwise cleaned, or for application at night prior to sleep.
Example 1- Hand and Body Lotion Vitamin A Palmitate 0.38% w/w Magnesium Ascorbyl Phosphate 0.75 Vitamin E Acetate 0.38 Alpha-Bisabolol 0.38 Panthenol (Pantothenyl Alcohol) 0.25 Edetate Disodium 0.10 Sodium Citrate 0.60 Trolamine (Triethanolamine) 1.70 Diethanolamine Methoxycinnamate (DEA Methoxycinnamate) 2.00 Aloe Vera Gel Concentrate 1.00 Beeswax, White 0.50 Mineral Oil, Light 4.00 Cetyl Palmitate 1.00 Soya Sterol 1.00 _ Cetyl Alcohol 2.00 Stearic Acid 3.00 Carbomer 934 0.10 Poly(Vinylpyrrolidone)/1-Eicosene Copolymer 1.00 Methylparaben'm 0.20 Propylparaben 7" 0.10 Imidazolidinyl Urea (Imidurea) 0.30 Bu.tylated Hydroxytoluene (BHT) 0.20 Cyclopentadecanolide 4.00 Fragrance QS
Water oS
Total 100.00% w/w Example 2 - Hand and Body Cream Vitamin A Palmitate 0.50 w/w Magnesium Ascorbyl Phosphate 0.75%
Vitamin E Acetate 1.50 Alpha-Bisabolol 1.00 Panthenol (Pantothenyl Alcohol) 1.00 Edetate Disodium 0.10 Sodium Citrate 0.60 Trolamine (Triethanolamine) 0.50 Diethanolamine Methoxycinnamate (DEA Methoxycinnamate) 2.00 Aloe Vera Gel Concentrate 1.00 Squalane 3.00 Cetyl Esters 2.00 Stearyl Alcohol 4.00 PEG-40 Stearate 4.00 Glyceryl Monostearate 3.00 Methylparaben 0.20 Propylparaben 0.10 Imidazolidinyl Urea (Imidurea) 0.30 Butylated Hydroxytoluene (BHT) 0.20 Silicone Oils 5.50 Cyclopentadecanolide 4.00 Fragrance QS
Water os Total 100.00% w/w Example 3 - Niqht Cream Vitamin A Palmitate 0.375% w/w Magnesium Ascorbyl Phosphate 3.000 Vitamin E Acetate 1.500 Alpha-Bisabolol 1.000 Panthenol (Pantothenyl Alcohol) 1.000 Edetate Disodium 0.100 Sodium Citrate 0.600 Trolamine (Triethanolamine) 0.500 Diethanolamine Methoxycinnamate (DEA Methoxycinnamate) 2.000 Aloe Vera Gel Concentrate 1.000 Squalane 3.000 Cetyl Esters 2.000 Mineral Oil, Light 4.000 Stearyl Alcohol 4.000 PEG-40 Stearate 2.500 Glyceryl Monostearate 4.500 Methylparaben 0.200 Propylparaben 0.100 Imidazolidinyl Urea (Imidurea) 0.300 Butylated Hydroxytoluene (BHT) 0.200 Silicone Oils 5.000 Cyclopentadecanolide 4.000 Fragrance QS
Water os Total 100.00% w/w The ingredients of the compositions of Examples 1 to 3 are formulated into a substantially homogeneous composition with standard mixing, stirring, or shearing equipment, including high shear, as well as motionless or other mixers, for example, at room temperature - 90 C, to form a creamy emulsion or lotion with a smooth feeling. The resultant compositions can be packaged, as appropriate, in plastic or aluminum tubes, glass or plastic: jars, or glass or plastic bottles. The compositions evidence gross physical stability even under drastic conditions, for example, at 60 C for 3 months.
The hand and body cream of Example 2 is evaluated for effectiveness in tests involvincf humans (15 caucasians, aged 50 years and older). The test subjects use the composition of Example 2 or a placebo cream, according to the blind code, for the first 2 months and then all subjects use the composition of Example 2. The test compositions are rubbed into the hands daily at night before the test subjects retire. The following techniques are used to evaluate the performance of the composition on the back of the hand: (A) photographs; (B) silastic castings; (C) ultrasound B-mode scans; (D) biopsies for histological examination; and (E) ballistometry. The overall effects observed as a result of the use in the evaluations of the composition of Example 2 are summarized hereafter.
On the basis of photographic assessments (A) above, a comparison of the subjects shows a gradual improvement in the appearance of the dorsal surface of the hands as a result of the use of the composition of Example 2. Study of the photographs reveal that there is a decrease in the number of lines, a decrease in the depth of the interossei, and a general improvement in the smoothness of the skin. Use of composition of Example 2 appears to improve both the quality of the stratum corneum and the hydration of the epidermis and dermis. Improvement in the interossei depth, as manifested by a decrease in the depth, would indicate a dermal improvement.
Silastic castings of (B) above are evaluated and compared by two independent scorers. Changes in the skin's topography are rated according -to the following scale:
positive response; no response or no change; and negative response or worsening. These results are then averaged. At 30 days, there is no significanit difference in the skin's topography. At 90 days, the silastic castings show that 60%
of the subjects exhibited a positive response in the skin's topography, and at 180 days, 731s of the subjects have a positive response.
On the basis of ultrasound evaluation of (C) above, the overall effects which are produced by use of the composition of Example 2 can be summarized by three observations: (1) the epidermis in most of the subjects becomes thicker and better hydrated; (2) the papillary derrnis increases in density; and (3) the reticular dermis increases in density. The time course of events shows a gradua7L increase in thickness and density to up to three or four months. After this period, the increase reaches a steady state or declines slightly.
These findings suggest an initial proliferative effect of the product on the epidermis followe:d by dermal restructuring.
From histological examination of (D) above, the stained sections are examined and evaluated for the following parameters: (1) epidermal thickriess; (2) size of the granular layer; (3) appearance of the stratum corneum; and (4) appearance of the dermis. Epidermal thickness increases by 19% over the course of the study, with a 50% increase being found in epidermal thickness in some subjects. Granular layer increases in all subjects to at least double in thickness. This increase is estimated by the number of granular cells. Stratum corneuni appearance is markedly different in most subjects. From a compacted initial appearance, the stratum corneum assumes a basket weave pattern that is associated with a younger epidermis. Dermal evaluation is difficult to assess in that no special stains are used. Overall most subjects will show an increase in cellularity of the dermis. This finding would be consistent with a restructuring process of the dermis.
On the basis of ballistometer evaluation of (E) above, 10 subjects have a positive response and 4 subjects have no significant change. One subject has a negative response.
This test measures dermal changes (not epidermal changes) and suggests that some restructuring of the dermis is occurring.
Based on the data that is obtained in the evaluation of the use of the composition of Example 2, conclusions can be made respecting the use of the composition of Example 2:
(1) the product is effective i:n increasing epidermal thickness; (2) the product is effective in producing a smooth, well structured stratum corneum; (3) the product increases epidermal proliferation; (4) the product increases skin elasticity; (5) the produc=t helps restore the dermal structure; and (6) the product is effective in restoring aging hands to a more youthful iappearance.
The next two examples are illustrative of the use of the enhancer of the present invention in sunscreen compositions.
Such compositions typically contain a plurality of sunscreen agents which are compounds that function to protect the skin by virtue of their ability to absorb various wavelengths of potentially harmful ultraviolet radiation. Sunscreen compositions should have a combination of properties including, for example: (A) the fundamental ability to absorb the involved radiation; (B) the ability to continue to absorb the radiation over a prolonged period of time; and (C) the ability to resist removal upon exposure to water and/or perspiration. It is known that various sunscreen agents penetrate the skin relatively rapidly, with subsequent loss to lower skin layers (dermis) and eventually to systemic circulation. In the development of the present invention, it has been observed that the sunscreen agent(s) in the composition of the present inverition is retained at higher concentrations for longer periods of time in the epidermis.
It is believed that concentratirig the sunscreen agent in the epidermis helps to provide a natural resistance to removal by exposure to physical contact and to water, including perspiration. The extent of this "retaining" effectiveness is dependent on the particular sunscreen agent(s) and carrier used and the concentration of the enhancer. The enhancer used in each of the compositions: of Examples 4 and 5 is cyclopentadecanolide.
Based on the data that is obtained in the evaluation of the use of the composition of Example 2, conclusions can be made respecting the use of the composition of Example 2:
(1) the product is effective i:n increasing epidermal thickness; (2) the product is effective in producing a smooth, well structured stratum corneum; (3) the product increases epidermal proliferation; (4) the product increases skin elasticity; (5) the produc=t helps restore the dermal structure; and (6) the product is effective in restoring aging hands to a more youthful iappearance.
The next two examples are illustrative of the use of the enhancer of the present invention in sunscreen compositions.
Such compositions typically contain a plurality of sunscreen agents which are compounds that function to protect the skin by virtue of their ability to absorb various wavelengths of potentially harmful ultraviolet radiation. Sunscreen compositions should have a combination of properties including, for example: (A) the fundamental ability to absorb the involved radiation; (B) the ability to continue to absorb the radiation over a prolonged period of time; and (C) the ability to resist removal upon exposure to water and/or perspiration. It is known that various sunscreen agents penetrate the skin relatively rapidly, with subsequent loss to lower skin layers (dermis) and eventually to systemic circulation. In the development of the present invention, it has been observed that the sunscreen agent(s) in the composition of the present inverition is retained at higher concentrations for longer periods of time in the epidermis.
It is believed that concentratirig the sunscreen agent in the epidermis helps to provide a natural resistance to removal by exposure to physical contact and to water, including perspiration. The extent of this "retaining" effectiveness is dependent on the particular sunscreen agent(s) and carrier used and the concentration of the enhancer. The enhancer used in each of the compositions: of Examples 4 and 5 is cyclopentadecanolide.
Example 4 - Suriscreen Lotion Benzophenone-3 (Oxybenzone) 3.0% w/w Diethanolamine Methoxycinnamate (DEA Methoxycinnamate) 3.0 Cyclopentadecanolide 4.0 Silicone Oil 5.0 Glyceryl Monostearate 5.0 PEG-40 Stearate 1.0 Sodium Lauryl Sulfate 0.5 Stearyl Alcohol 7,1 Cetyl Esters 5.0 Propylparaben 0.2 Butylated Hydroxytoluene (BHT) 0.2 Diethylene Glycol Monomethyl Ether 30.0 Water os Total 100.0% w/w Example 5 - Sunscreen Lotion Benzophenone-3 (Oxybenzone) 3.00% w/w Diethanolamine Methoxycinnamate (DEA Methoxycinnamate) 3.00 Cyclopentadecanolide 4.00 Silicone Oil 1.00 Glycerin (Glycerol) 5.00 Propylene Glycol 5.00 Carbomer 941 0.25 Squalane 3.00 Stearic Acid 1.50 Cetyl Esters 0.50 Cetyl Alcohol 0.50 Glyceryl Monostearate 3.00 PEG-40 Stearate 1.50 Trolamine (Triethanolamine) 0.50 Methylparaben 0.20 Propylparaben 0.10 Imidazolidinyl Urea (Imidurea) 0.30 Fragrance QS
Water oS
Total 100.00% w/w It should be appreciated that the present invention provides an effective means for improving the delivery to the body of a variety of types of mziterials which have beneficial effects on the body.
Water oS
Total 100.00% w/w It should be appreciated that the present invention provides an effective means for improving the delivery to the body of a variety of types of mziterials which have beneficial effects on the body.
Claims (18)
1. A composition which is effective in enhancing the qualities of skin or hair and which comprises: (A) a skin-treating compound or a hair-treating compound; (B) an enhancer having the structure wherein: X and Y are oxygen, sulfur, or an imino group of the structure =N-R, with the proviso that when Y is an imino group, X
is an imino group and when Y is sulfur, X is sulfur or an imino group; A is a group having the structure wherein X and Y are as defined above; m and n are integers having a value of from 1 to 20 and the sum of m + n is not greater than 25; p is an integer having a value of 0 or 1; q is an integer having a value of 0 or 1; r is an integer having a value of 0 or 1; and R is hydrogen or an alkyl group having from 1 to 6 carbon atoms and may be straight chained or branched; with the proviso that when p, q and r have a value of 0 and Y is oxygen, m + n is at least 11; (C) a carrier; and optionally (D) a cosmetic additive.
is an imino group and when Y is sulfur, X is sulfur or an imino group; A is a group having the structure wherein X and Y are as defined above; m and n are integers having a value of from 1 to 20 and the sum of m + n is not greater than 25; p is an integer having a value of 0 or 1; q is an integer having a value of 0 or 1; r is an integer having a value of 0 or 1; and R is hydrogen or an alkyl group having from 1 to 6 carbon atoms and may be straight chained or branched; with the proviso that when p, q and r have a value of 0 and Y is oxygen, m + n is at least 11; (C) a carrier; and optionally (D) a cosmetic additive.
2. A composition according to Claim 1 wherein the amount of said compound in said composition is at least about 0.01 wt.%.
3. A composition according to Claim 1 comprising about 0.1 to about 10 wt.% of said compound and about 0.1 to about 30 wt.% of said enhancer.
4. A composition according to Claim 3 comprising about 0.5 to about 3 wt.% of said compound and about 0.5 to about 10 wt.% of said enhancer.
5. A composition according to Claim 3 comprising about 2 to about 5 wt.% of said enhancer.
6. A composition according to Claim 2 which is an anti-oxidant composition and wherein said compound is an anti-oxidant material.
7. A composition according to Claim 1 wherein said enhancer is cyclopentadecanolide.
8. A composition according to Claim 2 wherein said enhancer is cyclopentadecanolide.
9. A composition according to Claim 3 wherein said enhancer is cyclopentadecanolide.
10. A composition according to Claim 4 wherein said enhancer is cyclopentadecanolide.
11. A composition according to Claim 5 wherein said enhancer is cyclopentadecanolide.
12. A composition according to Claim 6 wherein said enhancer is cyclopentadecanolide.
13. A composition according to Claim 1 wherein said composition comprises a skin-treating compound.
14. A composition according to Claim 7 wherein said composition comprises a skin-treating compound.
15. A composition according to Claim 13 in which the skin-treating compound is a sunscreen agent.
16. A use of a composition according to Claim 1 in the manufacture of a medicament for enhancing a property of the skin or the hair.
17. A use of a composition according to Claim 13 in the manufacture of a medicament for enhancing a property of the skin.
18. A use of a composition according to Claim 1 wherein said composition comprises a hair-treating compound, in the manufacture of a medicament for enhancing a property of the hair.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1997/000154 WO1998030198A1 (en) | 1997-01-09 | 1997-01-09 | Composition for enhancing skin or hair |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2275971A1 CA2275971A1 (en) | 1998-07-16 |
| CA2275971C true CA2275971C (en) | 2008-04-29 |
Family
ID=22260188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002275971A Expired - Fee Related CA2275971C (en) | 1997-01-09 | 1997-01-09 | Composition for enhancing skin or hair |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0964672A4 (en) |
| JP (1) | JP2002514203A (en) |
| KR (1) | KR100521787B1 (en) |
| AU (1) | AU731269B2 (en) |
| CA (1) | CA2275971C (en) |
| IL (1) | IL130663A (en) |
| WO (1) | WO1998030198A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19826499A1 (en) * | 1998-06-13 | 1999-12-16 | Beiersdorf Ag | Use of lactone, thiolactone and/or dithiolactone derivatives |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| US20050112084A1 (en) * | 2003-11-21 | 2005-05-26 | The Gillette Company | Topical cosmetic composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR940011209B1 (en) * | 1985-12-04 | 1994-11-29 | 시에 딘 | Transdermal administration of the drug |
| AU618517B2 (en) * | 1986-12-23 | 1992-01-02 | Eugene J. Van Scott | Additives enhancing topical actions of therapeutic agents |
| DE4121364A1 (en) * | 1991-06-28 | 1993-01-07 | Haarmann & Reimer Gmbh | ETHER OF 1-HYDROXY-HEX-5-EN-2-ON, PROCESS FOR THEIR PREPARATION AND THEIR USE AS FRAGRANCES |
| JPH05310543A (en) * | 1992-05-08 | 1993-11-22 | Kao Corp | Hair dye composition |
| US5540853A (en) * | 1994-10-20 | 1996-07-30 | The Procter & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
| WO1996012467A1 (en) * | 1994-10-20 | 1996-05-02 | The Procter & Gamble Company | Personal treatment compositions and/or cosmetic compositions containing enduring perfume |
| JPH08259444A (en) * | 1995-03-24 | 1996-10-08 | Earth Chem Corp Ltd | Bactericidal efficacy enhancer and oral composition containing the same |
| EP0855180A4 (en) * | 1996-06-11 | 2004-04-21 | Soda Aromatic Company Ltd | Antibacterial agents and cosmetics and clothes containing the same |
-
1997
- 1997-01-09 WO PCT/US1997/000154 patent/WO1998030198A1/en not_active Application Discontinuation
- 1997-01-09 AU AU18238/97A patent/AU731269B2/en not_active Ceased
- 1997-01-09 JP JP53514398A patent/JP2002514203A/en active Pending
- 1997-01-09 IL IL13066397A patent/IL130663A/en not_active IP Right Cessation
- 1997-01-09 KR KR10-1999-7006000A patent/KR100521787B1/en not_active Expired - Fee Related
- 1997-01-09 CA CA002275971A patent/CA2275971C/en not_active Expired - Fee Related
- 1997-01-09 EP EP97903746A patent/EP0964672A4/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| IL130663A (en) | 2005-12-18 |
| KR100521787B1 (en) | 2005-10-14 |
| KR20000069832A (en) | 2000-11-25 |
| AU731269B2 (en) | 2001-03-29 |
| EP0964672A4 (en) | 2001-03-21 |
| WO1998030198A1 (en) | 1998-07-16 |
| IL130663A0 (en) | 2000-06-01 |
| CA2275971A1 (en) | 1998-07-16 |
| EP0964672A1 (en) | 1999-12-22 |
| AU1823897A (en) | 1998-08-03 |
| JP2002514203A (en) | 2002-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6843863B2 (en) | Compositions containing at least two fatty acid esters of (poly) glycerol, and their use in cosmetics | |
| DE69210515T2 (en) | Cosmetic products | |
| EP0839520B1 (en) | Rinsing composition for the care of the skin | |
| JP3112436B2 (en) | In particular, the use of honey as a keratolytic agent to improve the brightness of the skin facial and treat wrinkles | |
| US6607735B2 (en) | Method for reducing the appearance of dark circles under the eyes | |
| KR101254615B1 (en) | Composition for prevention or alleviation of pigmentation | |
| KR20150095607A (en) | Oil-in-water emulsion composition | |
| DE602004003121T2 (en) | Cosmetic composition containing an organopolysiloxane elastomer and an aminosulfone compound. | |
| DE69417424T2 (en) | DETERGENT CONTAINING AN ALKANOAT AS A CONDITIONER | |
| CA2275971C (en) | Composition for enhancing skin or hair | |
| CN111840157A (en) | Camellia flower compound composition | |
| EP0679388B1 (en) | Cosmetic and/or dermatologic skin depigmentation composition and its use | |
| KR101690144B1 (en) | A method of preparing cosmetic composition for moisturizing the skin and promoting the differenciation of keratinocyte cell comprising the agar and the cosmetic composition prepared therefrom | |
| MXPA99006422A (en) | Composition for enhancing skin or hair | |
| CN103169644B (en) | Moisturizing lotion composition containing pansy flower extract and hydrolyzed pearl | |
| CN103211740B (en) | Moisturizing emulsion composition containing guava extractive and hydrolyzed pearl | |
| JP2006124399A (en) | Composition for improving skin or hair | |
| JP2001139425A (en) | Evaluation of cosmetic set and cosmetic set | |
| KR102649863B1 (en) | A cosmetic composition for enhancing elasticity | |
| KR20040030520A (en) | Cosmetics and treatment method for promoting maturation of cornified envelopes | |
| JP2001354518A (en) | External preparation for skin | |
| CN103211736B (en) | Smoothing and moisturizing emulsion composition containing extract of natural plant and hydrolyzed pearl | |
| CN1248907A (en) | Composition for enhancing skin or hair | |
| CN120346127A (en) | Skin care composition containing PQQ or salt thereof and preparation method and application thereof | |
| EP1941863A2 (en) | External preparation composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |